InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Woodrow Adam, Chief Executive Officer. Officer active across 1 companies, notably Paratek Pharmaceuticals, Inc.. Aggregated, 7 filings have been published. Total volume traded: €50k. The latest transaction was disclosed on 15 March 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations7 total
0101,250 shares0
Common Stock
SEC:0000904454-22-000270:0·
€25,0936,422 shares@ €3.9074100.0% of flow
Common Stock
SEC:0000904454-21-000838·
€25,0936,422 shares@ €3.907450.0% of flow
Common Stock
SEC:0000904454-21-000838:0·
037,500 shares0
Common Stock
SEC:0000904454-21-000622·
037,500 shares0
Common Stock
SEC:0000904454-21-000622:0·
042,955 shares0
Common Stock
SEC:0000904454-21-000520·
042,955 shares0
Common Stock
SEC:0000904454-21-000520:0·
7 of 7 declarations
About Woodrow Adam
Adam Woodrow is the President and Chief Commercial Officer of Paratek Pharmaceuticals, Inc. He is responsible for the strategic and operational leadership of the company. His leadership is essential in guiding Paratek towards innovation and efficiency.
